Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer 12 Dec 2021 A combination of five existing drugs keeps cancer at bay for longer in patients with a highly aggressive type of bone marrow cancer, a major new trial reveals. Find out more Show/Hide
Combination drug therapy can significantly benefit patients with newly diagnosed blood cancer 02 Aug 2021 A four-drug combination therapy that includes the novel drug carfilzomib can slow the progression of the blood cancer myeloma in patients who have been newly diagnosed with the disease, a phase III study has shown. Find out more Show/Hide
First Covid jab provides protection for most myeloma blood cancer patients 19 Apr 2021 A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus. Find out more Show/Hide
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020
New myeloma clinical trial launches with aim to transform treatment from one-size-fits-all approach 10 Oct 2017